IL33 and asthma: We suggest that this novel finding may be particularly important in asthma patients that carry IL1RL1 asthma risk alleles and have a lung microenvironment that promotes elevated levels of cleaved IL33 isoforms, leading to a more IL33‐driven disease amenable to targeting.